Frequently Asked Questions:
The COVID-19 pandemic has impacted the global osteoarthritis treatment market in various ways. While the supply chain and medicine manufacturing have been disrupted, the demand for osteoarthritis therapy has increased due to increased cases. The pandemic has also switched to telemedicine and online commerce, allowing businesses to increase their digital presence.
North America accounted for the most heightened global osteoarthritis treatment market share.
The increasing prevalence of osteoarthritis, expanding elderly population, and growing initiatives by government and private organizations to create awareness of the disease and its management are the primary factors for the growth of the osteoarthritis treatment market.
The analgesics segment had a major share in the global market in 2022.
The hospital pharmacies segment had a major share in the global market.